Blue Jet Healthcare Limited IPO Message Board (Page 16)

Company is a speciality pharmaceutical, healthcare ingredients and intermediates company, in business for last 55 years. In recent times, company has done business with over 400 customers across 39 countries. Company has 4 manufacturing facilities, 3 owned and 1 leased. Exports are 88% of sales and remaining are domestic.
It has 3 main segments, Contrast Media Intermediates (CMI) where its customers are 3 of world’s top 4. High intensity sweeteners (HIS) and Pharma Intermediates and API’s are the other 2.
Hands on experienced 2nd Gen promoter with 3rd gen groomed for future.
FY22-23, capacity utilisation for CMI was 72.6%, HIS was 71.5% and API/Pharma Intermediates was 48.6%.
R&D expenses are consistent at 0.3% to 0.4% of operational revenue.
High reliance on imports for RM, around 52% of RM is imported while balance is sourced locally. High % of exports gives a natural hedge against currency volatility.
Top 5 customers provide 73% of sales, with the biggest customer in Norway giving 60% of sales, as on 30-Jun-23. 3 largest RM suppliers made up 51.6% of cost of goods sold as on 30-Jun-23. High customer concentration given high tech, high quality products and clientele.
As on 30-Jun-23, company had 407 employees. As per EPFO, company deposited PF of 421 employees for sep-23 and 142 employees for Sep-22.
Decent cash flow. PBT for last 3 ½ years is Rs 702 cr while CFOB4T is Rs 561 cr.
For the last 3 consecutive years, company is showing forex gain, ranging from Rs 4 cr to Rs 16 cr.
Cash rich company with cash, bank balances and investments worth Rs 279 cr in books as on 30-Jun-23. Being cash rich company, finance costs are negligible.
Other income is largely made up of foreign exchange gains and increase in value of investments accounted through P&L.
YoY cost of goods sold increased from 41% to 45% in 22-23 while EBITDA dropped from 36.5% to 30.4%.
While 22-23 sales grew 6% YoY, other expenses grew 10%. Freight expenses reduced from Rs 32 cr to Rs 27 cr,
As on 30-Jun-23, of the total receivables of Rs 225 cr, Rs 18.7 cr is overdue for 6 months to 1 year while Rs 0.6 cr is overdue for more than 1 year.
4 direct / indirect tax related litigation of Rs 70 lacs while 1 case in labour court relating to employee dismissal. No major litigations.
Fully OFS issue so none of the IPO proceeds will go the company. Management holding post IPO will still be high @ 86%.
Q1FY24, Rs 12 cr of fixed assets added of which Rs 3.67 is for purchase of motor cars.
Decent anchor book, established and long standing customer relationships, high entry moat, experienced promoters, strong balance sheet, good margins

Is it possible that refund from this be available for Paragon Chemicals on 30th ? Considering LinkIntime ?

ASK AUTOMOTIVS LTD
IPO OPEN 7 NOV
IPO CLOSE 9 NOV

ISSUE SIZE: 900CR APPROX

How to check application wise subscription in SMALL HNI PORTION. Please reply

sir mene discount price pe ipo submitted kiya he kya mujhe tab bhi lagne k chances he
plz reply
​@newgen consultancy @Jetha Lal @AKIPO @allsir

No chances if you don't apply with cut off rate. Funds will be blocked unneccessarily

No, none...

GMP please...

Wrong no show subscription no cg forms

Applied in BHNI....

GMP : 39-41 ( New Low )

Can Anyone please guide how to use limited funds in these Upcoming Ipos.

If you have limited funds, apply in Blue jet and Paragon and ignore other Open IPO's

GMP : 65-66

GMP 25(New Low) :)
Source:- Investor Gain

Wrongly posted it was for IRM energy

Again a bad day for share market. Not a good sign. Long term investors, need not worry. StY invested. Difficult to say that how long this pain is going to stay. International conditions not good at all. We are not the experts to predict any thing on International conflicts. Beyond any body's thinking. Not to buy at present any thing in search of good gains. Keep funds available and wait for the International conditions improve.
May way of thinking to be on safe side.

please help me anyone who is using HUF account with sbi bank Saving account with net banking when i am apply ipo there is showing me You do not have any accounts with transaction rights. Kindly contact your branch. bank is not replying properly i am unable to do something someone tell me why is showing this ????
thanks adv

I had the same issue when I opened the HUF account in SBI.
You will have to contact your branch and get this resolved from here. I guess this has to do something with KYC.
Please note that, SBI doesn't open savings account when you open it under HUF.

Bahot Khamoshi he is page pr...

7 application applied. keep applying for sure listing gain.

Anyone having a/c in Utkarsh Small Finance Bank ?
Is it allowing ASBA Applications ?

No option in currently one of the Premium Savings account yet, that I have. They present an option to open 3 in 1 account with ICICI Direct

off topic....@newgen consultancy sir can you plz share ur expert views on whether we should hold or sell (by booking loss) below held since listing and what should be the short term targets. thanks in advance

Glenmark Life Sciences
Cartrade Tech
Aptus Value Housing Finance
Aditya Birla Sun Life AMC

thanks sir, so none of these are good stocks right

Also, any short term targets for below @Krishna T ✨ @newgen consultancy 

Restaurant Brands Asia
Heranba Industries
PB Fintech
EPL Ltd
Nazara Technologies
Netweb Technologies

>> thanks sir, so none of these are good stocks right.
These are good stocks but no-one can guarantee in short term because its quarterly result days and we normally see panic before and after result.

As far as JSW, Varun Beverages is concerned, it is portfolio stock any time. Let JSW give first result post IPO and then we can discuss and take it forward.

For rest of stocks you mentioned, not following except netweb which i don't see moving.

From rhp
-Company operates in 3 categories, contrast media intermediates ,(CMI). high intensity sweeteners and pharma APIs
-70% of world CMI market is dominated by 4 companies, out of which blue jet supplies to top 3. CMI are agents used in easy medical imaging. Also 75% of CMI exports from india is supplied by blue jet, Hence a market leader in this
-CMI has high entry barrier
-in sweeteners category customers are Colgate,Unilever etc
-75% rev from EUR, 15% from india and 5% from USA. Rn slowdown in API market in EUR but not sure about CMI
- rev mix of 3 categories -70%-CMI, 20% sweetener. API share increasing from past 3 years
-A top Single customer rev share is 63%. So its a dependency,mutually.
- Significant CAPEX taken last year. This is a good sign.
-Closely held group. Capital structure dates back to 1970's !!
- 3 manufacturing facilities, 1 upcoming
- Raw material is major cost, imported from china,norway 50% and ~50% from india
-Margins have been pretty much stable, maybe a little dip in 2023 due to slowing overall pharma market
- Trade receivables days ranges from 30 to 180, customers to customers. I could only find this and not 3 years data.

Can someone please tell me the DP name to filled while applying for ipo as I have account with prostocks

DP Name: ProStocks
DP ID: 12083200

Dp name sunligth h ya pro stocks

GMP : 68-69
Good demand since yesterday Night